|
HAI
Europe's Campaign on Direct-to-Consumer
Advertising of Prescription Medicines
2001
This
page consists of two sections:
Developments
Media attention on the issue
Developments
December
2001
Comments to the G10 group
from ANFs
"Response of the Portuguese National Association of Pharmacies
(ANF)"
Click here to read (also
in Word format and PDF
format)
5
December 2001
Position
statement of the Council of the Royal Pharmaceutical Society of Great
Britain (RPSGB).
Click here to read the
position statement.
23
November 2001
HAI
Europe's submission
to the G10 Medicines High Level Group on Innovation and Provision of
Medicines consultation paper.
August
2001
Is
the EU edging towards DTCA? Examining the consequences of industry's
latest lobby.
Click here to read the
HAI-Lights article
by Lisa Hayes.
25
July 2001
U.S.
Senator Byron Dorgan (Democrat, North Dakota) chairs meeting of the
Commerce Consumer Affairs Subcommittee to look at the impact direct
to consumer marketing of prescription drugs has on the cost of prescription
medicines and utilization of those medicines.
17
July 2001
HAI Europe criticises European Commission's scheduled
announcement on 18 July 2001 to allow "disease awareness" campaigns
for specific types of drugs. HAI Europe believes this decision will
open the door to direct-to-consumer advertising within the European
Union and will have negative impacts on public health.
Click here to read the
press release and background material
or to view the Commission's
full proposals on EU pharmaceutical legislation reform.
Media
attention
10
December 2001
The
Guardian: "Just no drug ads", article by Sarah Boseley.
Please
click here to read the article.
13
February 2001
NRC Handelsblad:
Fine of NLG 95,000: MSD entertains
doctors too much
13
January 2001
Trouw:
Topping off education in the mountains
|